Designs for Health Digestzymes Review

Both are betaine HCl + pepsin formulas for low stomach acid, so they share the same core acid mechanism and the same contraindications. The difference is the enzyme panel layered on top: Digestzymes leads on DPP-IV (targeting gluten and casein peptides) plus lactase, making it the better fit for a buyer whose problems span low acid AND specific protein sensitivities. Thorne (#2) leans harder on pancreatin and ox bile, making it the better fit for heavy, fatty meals plus low acid, and it carries NSF certification. Choose Digestzymes if gluten/casein/dairy peptides are part of your picture; choose Thorne if fat digestion and NSF certification matter more.

Anyone with reflux/GERD, gastritis, an active or suspected ulcer, or who takes acid-reducing medication (PPIs like omeprazole, H2 blockers like famotidine) should avoid it or talk to a clinician first — the same hard rule that applies to every betaine-HCl product. Adding hydrochloric acid to an already-irritated or acid-suppressed stomach can worsen symptoms or cause harm. Digestzymes is a targeted tool for low stomach acid, not a casual everyday enzyme. If any of those conditions apply, choose a non-HCl blend like Enzymedica Digest Gold (#1) or Pure Encapsulations (#3) instead.

No — this is a critical safety point. DPP-IV breaks down certain gluten and casein peptides and may offer mild comfort for non-coeliac sensitivity, but it does NOT make gluten safe for someone with coeliac disease. Coeliac is an immune reaction, not a digestion problem, and enzymes manage intolerances, not immune conditions. 'Gluten enzyme' products cannot protect a coeliac from gluten, and relying on one is dangerous. If you have coeliac disease, strict gluten avoidance is the only safe approach. DPP-IV is for mild sensitivity comfort only.

It's better thought of as a targeted tool than a daily catch-all. Because it contains betaine HCl, it's specifically for the low-acid buyer — someone whose protein meals sit heavy — and it carries real contraindications. For someone with normal stomach acid and a healthy pancreas, an HCl formula isn't appropriate and a broad blend would likely do little anyway. Use Digestzymes for the specific meals where the brick-in-the-stomach pattern shows up, alongside its peptide coverage if gluten/casein bother you, rather than reflexively every meal. Match the tool to a real, defined problem.

Yes, to a degree — the enzyme panel includes lipase, which supports fat digestion alongside the protein focus, so it's a genuinely complete heavy-meal option. Pancreatic enzymes (lipase in particular) are the established therapy for fat maldigestion (de la Iglesia-Garcia 2017). That said, if fatty meals are your primary problem and you want maximal fat support, Thorne's pancreatin + ox bile combination (#2) or NOW Super Enzymes' ox bile (#5) lean more heavily that way. Digestzymes' standout is the combination of acid support plus DPP-IV peptide coverage, with lipase as a solid supporting player.

The serving is 2 capsules, taken at the start of a meal — ideally a heavy, protein-dense meal that sits badly, or one containing the gluten/casein/dairy proteins that bother you. Take them with the first bites so the betaine HCl and enzymes mix with the food. The 180-capsule bottle runs about 3 months at 2 capsules per qualifying meal. As with any betaine-HCl product, if you ever experience burning or worsened reflux, stop immediately — that's a sign the acid mechanism is the wrong tool for you.

1. [1] de la Iglesia-Garcia 2017 PMID 27941156 — Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Meta-analysis of 17 RCTs (511 patients): pancreatic enzyme replacement therapy significantly improved fat absorption, nutrition, GI symptoms and quality of life versus placebo. Establishes the lipase/pancreatic-enzyme role behind Digestzymes' fat-digestion component. True exocrine insufficiency needs prescription PERT, not an OTC blend.
2. [2] Ianiro 2016 PMID 26806042 — Digestive Enzyme Supplementation in Gastrointestinal Diseases. Review across GI conditions: pancreatic enzymes, lactase and bile acids are well-supported for matched problems, while broad blends in people without a defined deficit are far weaker. Frames Digestzymes as a targeted acid + peptide tool for a specific combined picture, not a universal daily supplement.
3. [3] Ojetti 2010 PMID 20391953 — The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial. RCT: supplemental lactase improved breath-hydrogen and symptoms versus placebo in lactose-intolerant patients. Validates the lactase component of Digestzymes for dairy.